Related references
Note: Only part of the references are listed.Evidence-based pharmacotherapy of obsessive-compulsive disorder
Naomi A. Fineberg et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2012)
Aripiprazole as an Augmentation Agent in Treatment-Resistant Body Dysmorphic Disorder
Oezcan Uzun et al.
CLINICAL DRUG INVESTIGATION (2010)
Efficacy of olanzapine augmentation of paroxetine therapy in patients with severe body dysmorphic disorder
Shutaro Nakaaki et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2008)
Placebo-controlled study of pimozide augmentation of fluoxetine in body dysmorphic disorder
KA Phillips
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Pharmacotherapy of somatoform disorders
BA Fallon
JOURNAL OF PSYCHOSOMATIC RESEARCH (2004)
Insight in obsessive compulsive disorder and body dysmorphic disorder
JL Eisen et al.
COMPREHENSIVE PSYCHIATRY (2004)
An open-label study of citalopram in body dysmorphic disorder
KA Phillips et al.
JOURNAL OF CLINICAL PSYCHIATRY (2003)
Effectiveness of pharmacotherapy for body dysmorphic disorder: A chart-review study
KA Phillips et al.
JOURNAL OF CLINICAL PSYCHIATRY (2001)
Prevalence and clinical features of body dysmorphic disorder in adolescent and adult psychiatric inpatients
JE Grant et al.
JOURNAL OF CLINICAL PSYCHIATRY (2001)
Successful treatment of nondelusional body dysmorphic disorder with olanzapine: A case report
JE Grant
JOURNAL OF CLINICAL PSYCHIATRY (2001)
Characteristics of memory dysfunction in body dysmorphic disorder
T Deckersbach et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2000)
Share Paper
